Allied Private Wealth »

Abcellera Biologics shares owned by Allied Private Wealth

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Allied Private Wealth from 13F filings

Historical chart of Allied Private Wealth investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Allied Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Allied Private Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8k 400 7.10

More positions owned by Allied Private Wealth

Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Vanguard S&p 500 Etf Etf (VOO)
Capital Group Dividend Value Etf Etf (CGDV)
Amazon Stock (AMZN)
Nvidia Corporation Stock (NVDA)
Avantis International Equity Etf Etf (AVDE)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
American Century Diversified Municipal Bond Etf Etf (TAXF)
Janus Henderson Small/mid Cap Growth Alpha Etf Etf (JSMD)
Ishares U.s. Technology Etf Etf (IYW)
Fidelity Msci Information Technology Index Etf Etf (FTEC)
Blackstone Stock (BX)
Alphabet Inc Cap Stk Cl C Stock (GOOG)

View all positions for Allied Private Wealth

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Ubs Global Asset Management Americas
Leucadia National Corporation
UBS Group
Arrowpoint Asset Management
BlackRock
Driehaus Capital Management
Goldman Sachs Group
Bank of America Corporation
Alyeska Investment Group
Tudor Investment Corporation
Morgan Stanley

View all funds holding Abcellera Biologics